Esophageal Adenocarcinoma
10.1155/2019/1953497

Systematic Review with Meta-analysis: Association of Helicobacter pylori Infection with Esophageal Cancer


Esophageal Adenocarcinoma
10.1245/s10434-019-07836-4

ASO Author Reflections: In Gastric Cancer Patients with Primary Tumor Pathologic Complete Response, Treatment-Refractory Nodal Disease is an Ominous Sign


Esophageal Adenocarcinoma
10.1016/j.cgh.2019.11.014

Comparison of Phenotypes and Risk Factors for Esophageal Adenocarcinoma at Present vs Prior Decades.


Esophageal Adenocarcinoma
10.1111/apt.15233

Letter: dietary fibre benefits for the oesophagus—physical rather than metabolic action?


Esophageal Adenocarcinoma
10.1007/s11938-019-00214-9

Predictors of Progression in Barrett’s Esophagus


Esophageal Adenocarcinoma
10.1007/s00432-019-02955-7

Aberrant expression of Sec61α in esophageal cancers


Esophageal Adenocarcinoma
10.1158/1538-7445.AM2019-2826

Abstract 2826: Understanding associations among local microbiome, immune response, and efficacy of immunotherapy in esophageal cancer


Esophageal Adenocarcinoma
10.1016/S0016-5085(15)34020-8

The Evolving Landscape of Esophageal Cancer: A Four-Decade Analysis.


Esophageal Adenocarcinoma
10.1172/jci.insight.128439

Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma.


Esophageal Adenocarcinoma
10.1016/j.vgie.2018.09.018

Repair of upper-GI fistulas and anastomotic leakage by the use of endoluminal vacuum-assisted closure


Esophageal Adenocarcinoma
10.1245/s10434-019-08118-9

Is There a Role for Surgery in Treating Localized Esophageal Neuroendocrine Tumor?


Esophageal Adenocarcinoma
10.1007/s00535-019-01600-x

Relationship between Barrett’s esophagus and colonic diseases: a role for colonoscopy in Barrett’s surveillance


Esophageal Adenocarcinoma
10.1158/1538-7445.AM2019-878

Abstract 878: IGFBP2 is required to activate EGFR-DNA-PKcs pathway to protect esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage


Esophageal Adenocarcinoma
10.24926/IIP.V10I2.1633

The Effect of Zero Copayments on Medication Adherence in a Community Pharmacy Setting


Esophageal Adenocarcinoma
10.1093/ofid/ofz360.264

189. A Case Series of Elizabethkingia meningosepticum Bacteremia in the Cancer Population


Esophageal Adenocarcinoma
10.3389/fonc.2019.01320

VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study


Esophageal Adenocarcinoma
10.1007/s11605-019-04258-1

Impact of Radial Margin Status After Esophagectomy for Adenocarcinoma


Esophageal Adenocarcinoma
10.1007/s11938-019-00215-8

Challenges in Endoscopic Therapy of Dysplastic Barrett’s Esophagus


Esophageal Adenocarcinoma
10.1002/jbio.201900005

Wide-field optical property mapping and structured light imaging of the esophagus with spatial frequency domain imaging.


Esophageal Adenocarcinoma
10.1016/j.ejca.2019.04.020

FOLFOX alone or combined with rilotumumab or panitumumab as first-line treatment for patients with advanced gastroesophageal adenocarcinoma (PRODIGE 17-ACCORD 20-MEGA): a randomised, open-label, three-arm phase II trial.


Esophageal Adenocarcinoma
10.1158/2326-6066.CIR-18-0686

Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer


Esophageal Adenocarcinoma
10.1053/j.gastro.2018.09.038

Information on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk Factors.


Esophageal Adenocarcinoma
10.1007/978-3-319-97331-9_11

Gastroesophageal Reflux Disease (GERD)


Esophageal Adenocarcinoma
10.1093/jnci/djy082

Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Esophageal/Gastric Cardia Adenocarcinoma Among Men


Esophageal Adenocarcinoma
10.1016/j.jtcvs.2019.09.169

Outcome of delayed versus timely esophagectomy after chemoradiation for esophageal adenocarcinoma.


Esophageal Adenocarcinoma
10.1007/s00464-019-07205-y

Distribution of lymph node metastases in esophageal adenocarcinoma after neoadjuvant chemoradiation therapy: a prospective study


Esophageal Adenocarcinoma
10.1097/MCG.0000000000001215

Chronic Obstructive Pulmonary Disease and the Risk of Esophagitis, Barrett’s Esophagus, and Esophageal Adenocarcinoma


Esophageal Adenocarcinoma
10.1002/ijc.31840

Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma


Esophageal Adenocarcinoma
10.1021/acs.molpharmaceut.9b00185

Identification of Tumor Specific Peptide as EpCAM Ligand and Its Potential Diagnostic and Therapeutic Clinical Application.


Esophageal Adenocarcinoma
10.1186/s12885-019-5996-3

Silencing microRNA-330-5p increases MMP1 expression and promotes an invasive phenotype in oesophageal adenocarcinoma


Esophageal Adenocarcinoma
10.33612/diss.98628913

Modern view on multimodality treatment of esophageal cancer : thoughts on Patient Selection and Outcome


Esophageal Adenocarcinoma
10.2147/OTT.S162603

Upregulation of circulating miR130a is correlated with development of Barrett’s esophagus and esophageal adenocarcinoma


Esophageal Adenocarcinoma
10.1002/ijc.31936

Quantitative analysis of somatically acquired and constitutive uniparental disomy in gastrointestinal cancers


Esophageal Adenocarcinoma
10.1136/gutjnl-2019-BSGAbstracts.272

PTU-059 EMR for early barrett’s neoplasia: 15-years of experience from a UK tertiary referral centre


Esophageal Adenocarcinoma
10.1093/dote/doy081

Clustering of esophageal cancer among white men in the United States.


Esophageal Adenocarcinoma
10.1634/theoncologist.2019-0034

Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy.


Esophageal Adenocarcinoma
10.1007/978-3-319-96122-4_26

Epidemiology of Barrett’s Esophagus and Esophageal Cancer


Esophageal Adenocarcinoma
10.1177/000313481908500933

The Evolving Landscape of Esophageal Cancer: A Four-Decade Analysis


Esophageal Adenocarcinoma
10.1016/B978-0-323-40232-3.00003-0

Esophageal Mucosa in Health and Disease


Esophageal Adenocarcinoma
10.1002/ijc.32386

Anthropometric and reproductive factors and risk of esophageal and gastric cancer by subtype and subsite: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort


Esophageal Adenocarcinoma
10.3892/or.2019.7117

Single-cell intratumoral stemness analysis reveals the involvement of cell cycle and DNA damage repair in two different types of esophageal cancer


Esophageal Adenocarcinoma
10.1111/php.13206

Photodynamic Therapy for Gastrointestinal Cancer


Esophageal Adenocarcinoma
10.1016/j.ciresp.2019.02.010

Giant incarcerated diaphragmatic hernia post-esophagectomy (McKeown) with severe dilatation of gastric esophagoplasty.


Esophageal Adenocarcinoma
10.21037/JTD.2019.05.82

Associations of the microbiome and esophageal disease.


Esophageal Adenocarcinoma
10.1007/s11938-019-00250-5

An Approach to Obesity Management for Gastroenterologists and Hepatologists


Esophageal Adenocarcinoma
10.1007/s10552-019-01247-2

Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study


Esophageal Adenocarcinoma
10.3390/APP9112183

Ensemble of deep convolutional neural networks for classification of early Barrett’s neoplasia using volumetric laser endomicroscopy


Esophageal Adenocarcinoma
10.1007/978-3-030-15138-6_12

Impact of the Gastrointestinal Microbiome in Health and Disease: Co-evolution with the Host Immune System.


Esophageal Adenocarcinoma
10.21037/ATM.2019.01.84

Tumor location is an independent prognostic factor of esophageal adenocarcinoma based on the eighth edition of TNM staging system in Chinese patients.


Esophageal Adenocarcinoma
10.1016/j.jcmgh.2019.02.009

Glucose Drives Growth Factor–Independent Esophageal Cancer Proliferation via Phosphohistidine–Focal Adhesion Kinase Signaling


Esophageal Adenocarcinoma
10.3760/CMA.J.ISSN.2096-5400.2019.03.003

Analysis of clinicopathological characteristics and prognostic factors of 63 esophageal carcinoma patients with brain metastasis


Highly Related Keywords of Esophageal Adenocarcinoma